Cytogenetics and FLT3-ITD mutation predict clinical outcomes in non transplant patients with acute myeloid leukemia

Abstract Background Cytogenetic abnormalities and mutated genes indicate the role of consolidation therapy with hematopoietic stem cell transplantation (HSCT) or chemotherapy in acute myeloid leukemia (AML). In this study, we conducted a retrospective study in adult AML patients with newly diagnosed...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Pimjai Niparuck, Nittaya Limsuwanachot, Sulada Pukiat, Pichika Chantrathammachart, Budsaba Rerkamnuaychoke, Sutada Magmuang, Sithakom Phusanti, Kochawan Boonyawat, Teeraya Puavilai, Pantep Angchaisuksiri, Artit Ungkanont, Suporn Chuncharunee
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2019-01-01
Serie:	Experimental Hematology & Oncology
Soggetti:	Acute myeloid leukemia Cytogenetics FLT3-ITD NPM1 CEBPA
Accesso online:	http://link.springer.com/article/10.1186/s40164-019-0127-z
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!